Contribution of sexually transmitted infections to the sexual transmission of HIV

Current Opinion in HIV and AIDS

Volumn 5, Issue 4, 2010, Pages 305-310

  Ward, Helen ^a   Rönn, Minttu ^a  

^a St Mary's Campus ^*  (United Kingdom)

Author keywords

Herpes simplex virus type 2; HIV; Preventive interventions; STI

Indexed keywords

ACICLOVIR; RNA DIRECTED DNA POLYMERASE; VALACICLOVIR; VIRUS RNA;

ATTRIBUTABLE RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; ENZYME INHIBITION; HERPES SIMPLEX VIRUS 2; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; MALE HOMOSEXUAL; MATHEMATICAL MODEL; MIXED INFECTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS INHIBITION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION; WART VIRUS;

AFRICA; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, INFECTIOUS; HERPES GENITALIS; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; TREATMENT OUTCOME;

EID: 77953612602     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32833a8844     Document Type: Review

References (43)

1. Weber JN, McCreaner A, Berrie E, et al. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med 1986; 62:177-180.
2. Piot P, Laga M. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. BMJ 1989; 298:623-624.
3. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; ii:403-407.
4. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579-597.
5. Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res 2010; 85:276-285.
6. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346:530-536.
7. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-535.
8. Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexuallytransmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003; 361:645-652.
9. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291: 2555-2562.
10. Barnabas RV, Wasserheit JN. Riddle of the Sphinx revisited: the role of STDs in HIV prevention. Sex Transm Dis 2009; 36:365-367.
11. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005; 32:351-357.
12. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529.
13. Adimora AA, Schoenbach VJ, Floris-Moore MA. Ending the epidemic of heterosexual HIV transmission among African Americans. Am J Prev Med 2009; 37:468-471.
14. Sasse A, Defraye A. HIV infections and STI co-infections in men who have sex with men in Belgium: sustained increase in HIV diagnoses. Euro Surveill 2009; 14.
15. Miller M, Liao Y, Wagner M, Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis 2008; 35:696-702.
16. Patterson TL, Goldenberg S, Gallardo M, et al. Correlates of HIV, sexually transmitted infections, and associated high-risk behaviors among male clients of female sex workers in Tijuana, Mexico. AIDS 2009; 23:1765-1771.
17. Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev 2009; 11:140-156.
18. McCoy SI, Eron JJ, Kuruc JD, et al. Sexually transmitted infections among patients with acute HIV in North Carolina. Sex Transm Dis 2009; 36:372-374.
19. Zetola NM, Bernstein KT, Wong E, et al. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr 2009; 50:546-551.
20. van de Wijgert JH, Morrison CS, Brown J, et al. Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis 2009; 36:357-364.
21. Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53:537-543.
22. Menza TW, Hughes JP, Celum CL, Golden MR. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009; 36:547-555.
23. Jin F, Prestage GP, Imrie J, et al. Anal sexually transmitted infections and risk of HIV infection in homosexual men. J Acquir Immune Defic Syndr 2010; 53:144-149.
24. Auvert B, Lissouba P, Cutler E, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010; 53:111-116.
25. Chin-Hong PV, Husnik M, Cranston RD, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009; 23:1135-1142.
26. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
27. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35:946-959.
28. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008; 3:e2230.
29. Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. AIDS 2009; 23:1595-1598.
30. Tobian A, Ssempijja V, Kigozi G, et al. Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS 2009; 23:1589-1594.
31. Johnson KE, Sherman ME, Ssempiija V, et al. Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS 2009; 23:1807-1815.
32. Vanpouille C, Lisco A, Margolis L. Acyclovir: a new use for an old drug. Curr Opin Infect Dis 2009; 22:583-587.
33. Zuckerman RA, Lucchetti A, Whittington WL, et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS 2009; 23:479-483.
34. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008; 198:1804-1808.
35. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571.
36. Celum C, Wald A, Hughes J, et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119.
37. Lingappa JR, Kahle E, Mugo N, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One 2009; 4:e5272.
38. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
39. Vickerman PT, Ndowa F, O'Farrell N, et al. Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of STIs and HIV amongst female sex workers. Sex Transm Infect 2009. doi: 10.1136/sti.2008.034678. [Epub ahead of print]
40. Freeman EE, White RG, Bakker R, et al. Population-level effect of potential HSV2 prophylatic vaccines on HIV incidence in sub-Saharan Africa. Vaccine 2009; 27:940-946.
41. Gray RH, Wawer MJ. Reassessing the hypothesis on STI control for HIV prevention. Lancet 2008; 371:2064-2065.
42. Steen R, Wi TE, Kamali A, Ndowa F. Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm. Bull World Health Organ 2009; 87:858-865.
43. Chersich MF, Rees HV. Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS 2008; 22 (Suppl 4):S27-S40.